- Investing Ideas
- /
- Global Biotech Stocks
Global Biotech Stocks
Results
1373
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
1373 companies
Celltrion
Market Cap: ₩39.2t
A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.
A068270
₩177,900.00
7D
5.6%
1Y
-3.8%
Hansoh Pharmaceutical Group
Market Cap: HK$215.3b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$35.56
7D
-1.1%
1Y
76.9%
Sandoz Group
Market Cap: CHF 20.3b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
SDZ
CHF 46.35
7D
-2.1%
1Y
30.2%
BioNTech
Market Cap: US$24.0b
A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.
BNTX
US$98.08
7D
1.8%
1Y
-16.6%
Teva Pharmaceutical Industries
Market Cap: US$22.1b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$18.36
7D
-0.5%
1Y
3.5%
Innovent Biologics
Market Cap: HK$162.8b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$95.05
7D
-2.4%
1Y
112.2%
WuXi Biologics (Cayman)
Market Cap: HK$162.6b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$40.00
7D
2.8%
1Y
188.6%
Royalty Pharma
Market Cap: US$20.9b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$34.90
7D
-2.3%
1Y
23.8%
Sartorius Stedim Biotech
Market Cap: €17.6b
Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.
DIM
€174.50
7D
-5.6%
1Y
-5.1%
Biogen
Market Cap: US$20.2b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB
US$135.67
7D
-5.7%
1Y
-29.9%
Astellas Pharma
Market Cap: JP¥3.0t
Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.
4503
JP¥1,661.50
7D
0.7%
1Y
-3.3%
United Therapeutics
Market Cap: US$19.8b
A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
UTHR
US$425.42
7D
3.8%
1Y
18.9%
Sino Biopharmaceutical
Market Cap: HK$143.3b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$8.01
7D
-4.5%
1Y
125.0%
Genmab
Market Cap: DKK 115.0b
A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.
GMAB
DKK 1,852.50
7D
4.3%
1Y
16.0%
Waters
Market Cap: US$17.4b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$287.79
7D
-6.1%
1Y
-19.1%
Zhangzhou Pientzehuang Pharmaceutical
Market Cap: CN¥119.4b
Engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally.
600436
CN¥197.95
7D
-1.0%
1Y
-12.2%
Incyte
Market Cap: US$16.4b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$81.66
7D
-5.0%
1Y
25.4%
Akeso
Market Cap: HK$125.0b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$135.70
7D
3.6%
1Y
112.2%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$118.5b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$508.00
7D
-0.4%
1Y
200.1%
Shionogi
Market Cap: JP¥2.2t
Researches, develops, manufactures, and distributes pharmaceuticals, diagnostic reagents, and medical devices.
4507
JP¥2,612.50
7D
-1.4%
1Y
21.0%
Neurocrine Biosciences
Market Cap: US$14.5b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$140.89
7D
-3.3%
1Y
21.5%
Illumina
Market Cap: US$14.5b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$92.19
7D
-10.5%
1Y
-30.3%
Yunnan Baiyao GroupLtd
Market Cap: CN¥102.2b
Engages in the pharmaceutical business in China.
000538
CN¥57.28
7D
-2.1%
1Y
5.5%
Summit Therapeutics
Market Cap: US$14.2b
A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.
SMMT
US$20.50
7D
13.3%
1Y
-9.5%
Medpace Holdings
Market Cap: US$14.0b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$487.95
7D
-2.8%
1Y
49.6%
Cipla
Market Cap: ₹1.2t
Manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally.
CIPLA
₹1,509.70
7D
-4.3%
1Y
-6.9%
CSPC Pharmaceutical Group
Market Cap: HK$106.3b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$9.30
7D
-8.3%
1Y
70.3%
ICON
Market Cap: US$13.0b
A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
ICLR
US$162.53
7D
-9.4%
1Y
-43.2%
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.8b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€50.70
7D
-4.5%
1Y
0%
Eurofins Scientific
Market Cap: €10.8b
Provides various analytical testing and laboratory services worldwide.
ERF
€61.02
7D
-2.5%
1Y
7.7%
Dr. Reddy's Laboratories
Market Cap: ₹1.1t
Operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally.
500124
₹1,274.80
7D
-3.6%
1Y
-5.5%
Zydus Lifesciences
Market Cap: ₹1.0t
Engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.
ZYDUSLIFE
₹1,019.25
7D
-2.7%
1Y
-4.6%
Viatris
Market Cap: US$11.3b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$9.49
7D
-3.8%
1Y
-18.3%
Ipsen
Market Cap: €9.5b
Operates as a biopharmaceutical company worldwide.
IPN
€111.50
7D
-2.4%
1Y
0.2%
Shanghai Fosun Pharmaceutical (Group)
Market Cap: CN¥76.5b
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
CN¥30.30
7D
-4.1%
1Y
26.5%
Orion Oyj
Market Cap: €9.1b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€65.00
7D
-0.9%
1Y
31.2%